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Standards of practice: Carotid angioplasty and
stenting
Kenneth Ouriel, MD, Jay Yadav, MD, and Richard M. Green, MD, Cleveland, Ohio; and Rochester, NYCarotid endarterectomy has been used to treat carotid
bifurcation disease for more than 50 years. Over this period
of time, the indications for repair have been refined and the
surgical technique has undergone minor modification. This
operation has held up to the scrutiny of large multicenter
randomized trials, and more carotid endarterectomies are
now being performed than at any time in the history of the
operation. Although a cervical incision is inescapable, ca-
rotid endarterectomy is associated with a remarkably low
morbidity and mortality, especially when performed in
patients without severe medical comorbidities.
Despite the wide acceptance of carotid endarterec-
tomy, a consensus statement that summarizes the evidence-
based recommendations for treatment has never been pre-
pared by the vascular surgical societies. By contrast, several
interventional radiology societies have recently published
guidelines for carotid artery stenting, a relatively new ther-
apeutic option.1,2 These documents were prepared by the
joint Standards of Practice Committee of three societies:
the American Society of Interventional and Therapeutic
Radiology, the American Society of Neuroradiology, and
the Society of Interventional Radiology. Representatives
from radiology, interventional radiology, neurosurgery,
and interventional neuroradiology participated in the prep-
aration of this guideline document. Importantly, the radi-
ology document is not limited to a discussion of carotid
stenting; rather, the practice of carotid endarterectomy is a
major component of the publication—with recommenda-
tions on the appropriateness of endarterectomy for patients
with and without symptoms.
The radiology documents suggests that evidence to
support the use of carotid endarterectomy for symptom-
free patients is based on but one randomized trial, the
Asymptomatic Carotid Atherosclerosis Study (ACAS).3
Recently reported data from the Asymptomatic Carotid
Surgery Trial, a randomized European trial of carotid end-
arterectomy versus best medical management in patients
with asymptomatic stenoses, also demonstrated a statisti-
cally significant benefit for surgery after 5-year follow-up.4
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that ACAS failed to find benefit for the end point of major
stroke, and that even a slight reduction in the risk of
medical management of asymptomatic stenosis with the
availability of contemporary pharmaceutical agents might
render endarterectomy nonbeneficial in the majority of
symptom-free patients. A review of the ACAS publication,
however, suggests that after a median follow-up of 2.7
years, endarterectomy was associated with a significant
reduction in the risk of ipsilateral stroke and any perioper-
ative stroke or death (risk reduction 53%, 95% confidence
interval 22%-72%).
Concerning carotid artery stenting, the radiology
guidelines document opines that the benefit of embolic
protection devices is controversial and without evidence
based upon randomized, prospective studies. Such evi-
dence may never be available, but each of the ongoing
carotid stent trials mandates the use of such protection
devices. Further, in a conference of opinion leaders, con-
sensus was reached on the uniform use of emboli protection
devices once they become available.5 The Global Carotid
Artery Stent Registry documented a 5.3% rate of stroke and
procedure-related death in 6753 cases done without the
use of an emboli protection, contrasted with a 2.2% rate in
4221 cases performed with emboli protection.6 A system-
atic review of the literature revealed that 2537 carotid stent
procedures had been performed without protection de-
vices; 896 procedures had been performed with protection
devices.7 Both groups were similar with respect to demo-
graphics, risk factors, age, and indications. The combined
30-day stroke and death rate was 1.8% in patients treated
with cerebral protection devices compared with 5.5% in
patients treated without cerebral protection devices (P 
.001). While this data did not originate from randomized,
prospective studies, certain procedures and techniques be-
come the standard of care without the availability of Level
One evidence when their benefit is so intuitively clear that
randomized trials cannot be justified. The use of heparin for
carotid endarterectomy is one such example. Although
never tested in a randomized trial, anticoagulation during
endarterectomy achieved widespread use because of its
intuitive value, and subsequent surveys of practice outcome
have supported its benefit.8 We strongly believe that em-
bolic protection devices for carotid stenting are a similar
example and practitioners should be discouraged from
performing carotid stenting in routine situations without
use of such a device.
At best, the radiology guidelines document for carotid
stenting is premature. In currently available trials, such as
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High-Risk for Endarterectomy (SAPPHIRE) trial, there
are not sufficient available data to separate recommenda-
tions for patients with and without symptoms on the basis
of the outcome of carotid stenting .9 Recommendations on
the appropriateness of carotid stenting for stenosis second-
ary to fibromuscular dysplasia, giant cell arteritis, and arte-
rial dissection are based on a paucity of even anecdotal data.
Even more controversial than recommendations on the
indications for carotid stenting are the stated requirements
for physician qualifications in the radiology guidelines doc-
ument. The radiology societies recommended a minimum
of 200 supervised diagnostic cervicocerebral angiograms
with documented acceptable indications and outcomes
prior to credentialing for independent carotid stenting—a
requirement that appears self-serving and not consistent
with current practice, where the indications for diagnostic
carotid procedures are strikingly few.
In direct contrast to the radiology guidelines docu-
ments’ requirement for a large number of diagnostic pro-
cedures is the rather low minimum requirement for inter-
ventional therapeutic procedures for credentialing. Arterial
stent experience is suggested, defined by a threshold of 25
non–carotid stent procedures and the completion of a
hands-on carotid stenting course with only four successful
carotid stenting procedures as principal operator. An alter-
native to this pathway is also suggested—successful com-
pletion of 10 carotid stenting procedures as the primary
interventionist, with supervision by an on-site qualified
physician. These numbers are significantly lower than the
minimal requirements to participate in any of the ongoing
clinical trials of carotid stenting—for example, the Carotid
Revascularization Endarterectomy versus Stent Trial.10 We
believe that the minimum number of carotid stent proce-
dures to establish credentialing should be dependent on the
practitioner’s endovascular experience, but in all cases
should exceed the thresholds specified in the radiology
guideline documents. The skills required to safely perform
carotid stenting are natural extensions of those utilized in
treating other arterial targets. Those qualified in these other
areas, whether coronary or noncoronary, should be able to
learn the unique aspects of carotid stenting with cerebral
protection devices. Furthermore, the use of adjunctive
training methods such as computer-based simulation is
likely to alter the numbers of both diagnostic and therapeu-
tic studies necessary to achieve proficiency.Although specialties may differ over the precise indica-
tions for carotid stenting and the determination of which
practitioners are best suited to perform the procedure, few
would dispute that carotid stenting can be a useful clinical
tool and one that should be approved for use by the Food
and Drug Administration and reimbursable by the Centers
for Medicare and Medicaid Services and other payers in
appropriate patients. At a time when the medical commu-
nity is interested in these goals, we believe that the stake-
holders of carotid stenting should join forces to accomplish
their goals. Rather than creating position papers by single
societies or even groups of societies, it is incumbent upon
us to work together to assure accessibility of carotid stent-
ing and to continue to garner industrial and government
support for well-designed clinical trials to evaluate new
technology.
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